Loading...
Antimetabolite Treatment for Pancreatic Cancer
Pancreatic cancer is a deadly and aggressive disease. Less than 1% of diagnosed patients survive 5 years with an average survival time of only 4–8 months. The only option for metastatic pancreatic cancer is chemotherapy where only the antimetabolites gemcitabine and 5-fluorouracil are used clinicall...
Saved in:
| Published in: | Chemotherapy (Los Angel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494102/ https://ncbi.nlm.nih.gov/pubmed/26161298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2167-7700.1000137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|